Publications by authors named "Atish D Choudhury"

Claim this Profile
P
Publisher Correction: Testosterone suppression and recovery with abiraterone/prednisone monotherapy after early discontinuation of LHRH-A in hormone sensitive prostate cancer.
Autumn Gagnon, Caiwei Zhong, Wanling Xie, Lynne Morlock, Dory Freeman, Atish D Choudhury

Prostate Cancer Prostatic Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testosterone suppression and recovery with abiraterone/prednisone monotherapy after early discontinuation of LHRH-A in hormone sensitive prostate cancer.
Autumn Gagnon, Caiwei Zhong, Wanling Xie, Lynne Morlock, Dory Freeman, Atish D Choudhury

Prostate Cancer Prostatic Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of bone marrow disease on hematologic toxicity and response to [Lu]Lu-PSMA-617 therapy: insights from PSMA-PET/CT imaging.
Nuno Borges, Meryam Losee, Mofei Liu, Su-Chun Cheng, Arda Könik, Atish D Choudhury

Eur J Nucl Med Mol Imaging· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma epigenomic profiling reveals treatment-emergent squamous transformation in prostate cancer.
Karl Semaan, Rashad Nawfal, John Canniff, Hunter Savignano, Ji-Heui Seo, Atish D Choudhury

NPJ Precis Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Fixed-duration Systemic Treatment and Metastasis-directed Radiotherapy for Oligometastatic Hormone-sensitive Prostate Cancer.
Praful Ravi, Caiwei Zhong, Wanling Xie, Emma Kelly, Bridget Whelpley, Atish D Choudhury

Eur Urol Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of Subsequent Therapies After Lu-Vipivotide Tetraxetan for Metastatic Castrate-Resistant Prostate Cancer: A Tertiary Cancer Center Experience.
Meryam Losee, Michael Kavanaugh, Mofei Liu, Nuno Borges, Veronica Haberman, Atish D Choudhury

Prostate· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-purity CTC RNA sequencing identifies prostate cancer lineage phenotypes prognostic for clinical outcomes.
Marina N Sharifi, Jamie M Sperger, Amy K Taylor, Katharine E Tippins, Shannon R Reese, Atish D Choudhury

Cancer Discov· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DirectHRD enables sensitive scar-based classification of homologous recombination deficiency.
Ruolin Liu, Eugenia Roberts, Heather A Parsons, Elizabeth H Stover, Atish D Choudhury

Nucleic Acids Res· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of normal bone and osseous metastases in castration-resistant prostate cancer using SPECT/CT with xSPECT Quant: prospective imaging sub-study of a phase 2 clinical trial investigating the combination of pembrolizumab plus radium-223 compared to radium-223 alone.
Matthew S Robertson, Yating Wang, SuChun Cheng, Hyesun Park, Shahar Glomski, Atish D Choudhury

Radiol Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin resistance during androgen deprivation therapy in men with prostate cancer.
Shehzad Basaria, Mary-Ellen Taplin, Marie McDonnell, Donald C Simonson, Alexander P Lin, Atish D Choudhury

Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer.
Atish D Choudhury, Lucia Kwak, Alexander Cheung, Kathryn M Allaire, Jaqueline Marquez

Cancer Immunol Res· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postradical prostatectomy prostate-specific antigen outcomes after 6 versus 18 months of perioperative androgen-deprivation therapy in men with localized, unfavorable intermediate-risk or high-risk prostate cancer: Results of part 2 of a randomized phase 2 trial.
Rana R McKay, Wanling Xie, Xiaoyu Yang, Andres Acosta, Dana Rathkopf, Atish D Choudhury

Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Panel-Based Mutational Signature of Mismatch Repair Deficiency is Associated With Durable Response to Pembrolizumab in Metastatic Castration-Resistant Prostate Cancer.
Daniel Boiarsky, Doga C Gulhan, Hunter Savignano, Gitanjali Lakshminarayanan, Heather M McClure, Atish D Choudhury

Clin Genitourin Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FinaleMe: Predicting DNA methylation by the fragmentation patterns of plasma cell-free DNA.
Yaping Liu, Sarah C Reed, Christopher Lo, Atish D Choudhury, Heather A Parsons

Nat Commun· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late Subacute Cerebral Hematoma Mimicking a Metastasis on PSMA PET/CT.
Nuno Vaz, Eric Dietsche, Michael A Mooney, Atish D Choudhury, Heather A Jacene

Clin Nucl Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FinaleMe: Predicting DNA methylation by the fragmentation patterns of plasma cell-free DNA.
Yaping Liu, Sarah C Reed, Christopher Lo, Atish D Choudhury, Heather A Parsons

bioRxiv· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MR-guided prostate SBRT in prostate cancer patients with low-volume metastatic disease.
Shalini Moningi, Atish D Choudhury, Neil E Martin, Paul L Nguyen, Anthony V D'Amico

World J Urol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretest Video Education Versus Genetic Counseling for Patients With Prostate Cancer: ProGen, A Multisite Randomized Controlled Trial.
Huma Q Rana, Jill E Stopfer, Michelle Weitz, Lindsay Kipnis, Diane R Koeller, Atish D Choudhury

JCO Oncol Pract· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of PARP Inhibitors in Targeting Castration-Resistant Prostate Cancer.
Kent W Mouw, Atish D Choudhury

Cancer Treat Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutual ATRaction: Assessing Synergy of Berzosertib with Sacituzumab Govitecan.
Stephanie A Berg, Atish D Choudhury

Clin Cancer Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining Patient Benefits from High-intensity Intermittent Therapy for Hormone-sensitive Prostate Cancer.
Praful Ravi, Atish D Choudhury

Eur Urol Focus· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes.
Navonil De Sarkar, Robert D Patton, Anna-Lisa Doebley, Brian Hanratty, Mohamed Adil, Atish D Choudhury

Cancer Discov· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Implementation of Lu-PSMA-617 in the United States: Lessons Learned and Ongoing Challenges.
Praful Ravi, Bridget Whelpley, Emma Kelly, Andrew Wolanski, Jolivette Ritzer, Atish D Choudhury

J Nucl Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of Niraparib in Combination with Radium-223 for the Treatment of Metastatic Castrate-Resistant Prostate Cancer.
Zachary Quinn, Benjamin Leiby, Guru Sonpavde, Atish D Choudhury, Christopher Sweeney

Clin Cancer Res· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer.
Takuya Tsujino, Tomoaki Takai, Kunihiko Hinohara, Fu Gui, Takeshi Tsutsumi, Atish D Choudhury

Nat Commun· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis